MATRIX PHARMACORP PRIVATE LTD
MATRIX PHARMACORP PRIVATE LTD (India) holds 229 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 40 active ingredients, holds 2 active Type IV (excipient) Drug Master Files and is linked to 5 FDA-registered manufacturing sites. 2 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “MATRIX PHARMACORP PRIVATE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/matrix-pharmacorp-private-ltd
Overview
MATRIX PHARMACORP PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 228 active FDA Type II Drug Master Files, covering ABACAVIR SULFATE USP; ABALOPARATIDE; ACYCLOVIR USP; ALENDRONATE SODIUM USP (TRIHYDRATE); ALLOPURINOL USP; ALMOTRIPTAN MALATE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which MATRIX PHARMACORP PRIVATE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
MATRIX PHARMACORP PRIVATE LTD holds 229 active (230 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- BRIGATINIBActive2026-09-03
- SUGAMMADEX SODIUMActive2026-03-30
- AVATROMBOPAG MALEATEActive2025-12-31
- CABOTEGRAVIRActive2025-09-30
- CABOTEGRAVIR SODIUMActive2025-09-29
- SERTRALINE HYDROCHLORIDE USP (FORM-I)Active2025-09-26
- PHENTOLAMINE MESYLATE USP (PROCESS II)Active2025-06-25
- TAPINAROFActive2025-02-05
- ALPRAZOLAM USP (FORM-III)Active2025-01-02
- OLSALAZINE SODIUMActive2023-12-20
- FELBAMATE USP (FEL)Active2023-12-01
- DORAVIRINEActive2023-10-06
- PAROXETINE HYDROCHLORIDE USP (HEMIHYDRATE)Active2023-09-29
- SELEGILINEActive2023-09-27
- BICTEGRAVIR SODIUMActive2022-09-16
- TOFACITINIB CITRATEActive2021-12-15
- TENOFOVIR ALAFERNAMIDE MONOFUMARATEActive2021-12-10
- ABALOPARATIDEActive2021-12-03
- IRON SUCROSEActive2020-12-17
- BEDAQUILINE FUMARATEActive2020-12-14
- EFINACONAZOLEActive2019-12-20
- MESALAMINE USPActive2019-12-05
- SODIUM FERRIC GLUCONATE COMPLEXActive2019-12-03
- PLECANATIDEActive2019-11-27
- CANAGLIFLOZIN HEMIHYDRATEActive2019-11-27
- PYRAZINAMIDE USPActive2019-11-01
- RIVAROXABAN USPActive2019-10-15
- LEDIPASVIRActive2018-12-28
- SUCROFERRIC OXYHYDROXIDEActive2018-12-27
- APIXABANActive2018-12-19
- LANTHANUM CARBONATE (PROCESS 2)Active2018-12-11
- DIPHENOXYLATE HYDROCHLORIDE USPActive2018-11-30
- IRON DEXTRANActive2018-11-27
- DROXIDOPAActive2018-09-18
- FERRIC CARBOXYMALTOSEActive2018-08-02
- PLERIXAFOR USPActive2018-01-07
- SINCALIDEActive2018-01-07
- PONATINIB HYDROCHLORIDEActive2018-01-07
- SUGAMMADEX SODIUMActive2018-01-07
- REGADENOSONActive2018-01-07
- ATROPINE SULFATE USPActive2017-12-27
- VERAPAMIL HYDROCHLORIDE USPActive2017-12-22
- PALBOCICLIBActive2017-12-21
- LEUPROLIDE ACETATE USPActive2017-12-19
- MAFENIDE ACETATE USPActive2017-12-19
- CHLORTHALIDONE USPActive2017-12-13
- SACUBITRIL/VALSARTANActive2017-12-07
- APREMILAST (CRYSTALLINE)Active2017-11-08
- SOFOSBUVIRActive2017-09-01
- VORTIOXETINE HYDROBROMIDEActive2017-06-24
Showing the 50 most relevant of 230 Drug Master Files (active first). The full list is in the FDA DMF list.
Excipient Drug Master Files
MATRIX PHARMACORP PRIVATE LTD holds 2 active (2 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- TRIETHYLAMMONIUM SUCROSE OCTASULFATEActive2023-03-28
- SALCAPROZATE SODIUMActive2022-12-02
Registered manufacturing sites (5)
Physical sites registered with the US FDA and resolved to MATRIX PHARMACORP PRIVATE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- Matrix Pharmacorp Private LimitedVisakhapatnam, India · API manufacture
- Matrix Pharmacorp Private LimitedVisakhapatnam, India · API manufacture
- Matrix Pharmacorp Private LimitedVizianagaram, India · API manufacture
- Matrix Pharmacorp Private LimitedHyderabad, India · API manufacture
- Matrix Pharmacorp Private LimitedHyderabad, India · API manufacture
FDA compliance signals
2 FDA enforcement records linked to this company.
- warning_letter2020-08-20
FDA Warning Letter (drug product)
- warning_letter2019-11-05
FDA Warning Letter (drug product)
Is this MATRIX PHARMACORP PRIVATE LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.